Publication | Closed Access

Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells

Aromatase InhibitorsBreast OncologyEndocrine-related CancerMedicineBreast CancerAromatasePharmacotherapyAnti-tumor EfficacyAnti-cancer AgentNew 7α-Substituted AndrostanesPharmacologyRadiation OncologyTumor BiologyDrug Discovery